These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2001189)

  • 1. Heterogeneity in spasmodic dysphonia. Neurologic and voice findings.
    Pool KD; Freeman FJ; Finitzo T; Hayashi MM; Chapman SB; Devous MD; Close LG; Kondraske GV; Mendelsohn D; Schaefer SD
    Arch Neurol; 1991 Mar; 48(3):305-9. PubMed ID: 2001189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spasmodic dysphonia.
    Rosenfield DB
    Adv Neurol; 1988; 50():537-45. PubMed ID: 3400508
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
    J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
    Barkmeier JM; Case JL; Ludlow CL
    J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia.
    Inagi K; Ford CN; Bless DM; Heisey D
    J Voice; 1996 Sep; 10(3):306-13. PubMed ID: 8865102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofeedback therapy for spastic dysphonia.
    Watanabe H; Komiyama S; Ryu S; Kannae S; Matsubara H
    Auris Nasus Larynx; 1982; 9(3):183-90. PubMed ID: 7168715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
    Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology of spasmodic dysphonia.
    Schaefer SD
    Laryngoscope; 1983 Sep; 93(9):1183-204. PubMed ID: 6136880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adductor spastic dysphonia: heterogeneity of physiologic and phonatory characteristics.
    Davis PJ; Boone DR; Carroll RL; Darveniza P; Harrison GA
    Ann Otol Rhinol Laryngol; 1988; 97(2 Pt 1):179-85. PubMed ID: 3355046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spastic/spasmodic vs. tremulous vocal quality: motor speech profile analysis.
    Lundy DS; Roy S; Xue JW; Casiano RR; Jassir D
    J Voice; 2004 Mar; 18(1):146-52. PubMed ID: 15070235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral Vocal Fold Medialization: A Treatment for Abductor Spasmodic Dysphonia.
    Dewan K; Berke GS
    J Voice; 2019 Jan; 33(1):45-48. PubMed ID: 29132808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adductor spastic dysphonia as a sign of essential (voice) tremor.
    Aronson AE; Hartman DE
    J Speech Hear Disord; 1981 Feb; 46(1):52-8. PubMed ID: 7206678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurologic aspects of spasmodic dysphonia.
    Rosenfield DB; Donovan DT; Sulek M; Viswanath NS; Inbody GP; Nudelman HB
    J Otolaryngol; 1990 Aug; 19(4):231-6. PubMed ID: 2213994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection.
    Ludlow CL; Naunton RF; Terada S; Anderson BJ
    Otolaryngol Head Neck Surg; 1991 Jun; 104(6):849-55. PubMed ID: 1908979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical investigations of adductor spastic dysphonia.
    Hartman DE; Abbs JH; Vishwanat B
    Ann Otol Rhinol Laryngol; 1988; 97(3 Pt 1):247-52. PubMed ID: 3377392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A probe into the relationship between spasmodic dysphonia and laryngeal paralysis].
    Yang S; He P; Lu S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Dec; 33(6):328-30. PubMed ID: 11938840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
    Kendall KA; Leonard RJ
    J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A separation of innate and learned vocal behaviors defines the symptomatology of spasmodic dysphonia.
    Guiry S; Worthley A; Simonyan K
    Laryngoscope; 2019 Jul; 129(7):1627-1633. PubMed ID: 30582159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.